Procter & Gamble CEO Paul Gama Granted 12,517 RSUs

Paul Gama, CEO of Health Care at Procter & Gamble Co (NYSE:PG), received a significant restricted stock unit (RSU) grant on October 1, 2026. The grant consisted of 12,517 shares of common stock, awarded under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The transaction was recorded at a price of $0, as is typical for RSU awards.

Following this grant, Gama's direct beneficial ownership of Procter & Gamble common stock increased to 53,348.8803 shares. Additionally, he holds an indirect beneficial ownership of 1,173.4717 shares through a Retirement Plan Trustee. The total figures reflect his holdings as of October 1, 2026.

The SEC Form 4, filed on October 5, 2026, details the transaction and was signed by Jennifer DollardSmith as attorney-in-fact for Paul Gama. The filing clarifies that the transaction was not executed under a Rule 10b5-1(c) trading plan, as the relevant checkbox remains unmarked.